Listed

MiniMed Group, Inc.

MMEDNasdaqCIK 2062583HealthcareFiscal year ends Dec 31

Latest reported revenue, Q1 FY2027$843.0mRevenue, Q1 FY2027, three months to 2026-07-31$843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figureThree months to Jul 31, 2026, from the 10-Q filed Sep 8, 2026.

Latest quarter: Q1 FY2027

Three months to Jul 31, 2026, against the same quarter a year earlier.

  • Revenue$843.0mRevenue, Q1 FY2027, three months to 2026-07-31$843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure+16.6% on a year earlier
  • Gross margin55.2%Gross margin, Q1 FY2027, three months to 2026-07-31. gross profit / revenueGross profit: $465.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure−1.4 pts on a year earlier
  • Operating margin0.6%Operating margin, Q1 FY2027, three months to 2026-07-31. operating income / revenueOperating income: $5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure+2.4 pts on a year earlier
  • Net margin0.0%Net margin, Q1 FY2027, three months to 2026-07-31. net income / revenueNet income: $0. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure+2.6 pts on a year earlier
  • Diluted EPS$0.00Diluted EPS, Q1 FY2027, three months to 2026-07-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figureSign changed from a year earlier
  • Free cash flow−$90.0mFree cash flow, Q1 FY2027, three months to 2026-07-31. operating cash flow − capital expenditureOperating cash flow: −$49.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Capital expenditure: $41.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure+53.6% on a year earlier

Last eight quarters

Full statements
Revenue$843.0mGross margin 55.2%
Diluted EPS$0.00, Q1 FY2027
Free cash flow−$90.0m, Q1 FY2027
MiniMed Group, Inc., key figures for the last eight quarters
Line itemUnitperiod not labelled2024-10-25period not labelled2025-01-24period not labelled2025-04-25period not labelled2025-07-25period not labelled2025-10-24Q3 FY20262026-01-23Q4 FY20262026-04-24Q1 FY20272026-07-31Shape over the periods
Revenue$mnot reported (Revenue not reported)687Revenue, period not labelled, three months to 2025-01-24$687.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure724Revenue, period not labelled, three months to 2025-04-25$724.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure723Revenue, period not labelled, three months to 2025-07-25$723.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported (Revenue not reported)790Revenue, Q3 FY2026, three months to 2026-01-23$790.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure837Revenue, Q4 FY2026, three months to 2026-04-24$837.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure843Revenue, Q1 FY2027, three months to 2026-07-31$843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Gross margin%not reported (Gross profit and Revenue not reported)57.5%Gross margin, period not labelled, three months to 2025-01-24. gross profit / revenueGross profit: $395.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Revenue: $687.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure55.9%Gross margin, period not labelled, three months to 2025-04-25. gross profit / revenueGross profit: $405.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Revenue: $724.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure56.6%Gross margin, period not labelled, three months to 2025-07-25. gross profit / revenueGross profit: $409.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $723.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported (Gross profit and Revenue not reported)45.8%Gross margin, Q3 FY2026, three months to 2026-01-23. gross profit / revenueGross profit: $362.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Revenue: $790.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure57.3%Gross margin, Q4 FY2026, three months to 2026-04-24. gross profit / revenueGross profit: $480.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Revenue: $837.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure55.2%Gross margin, Q1 FY2027, three months to 2026-07-31. gross profit / revenueGross profit: $465.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Operating margin%not reported (Operating income and Revenue not reported)3.1%Operating margin, period not labelled, three months to 2025-01-24. operating income / revenueOperating income: $21.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Revenue: $687.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(20.4%)Operating margin, period not labelled, three months to 2025-04-25. operating income / revenueOperating income: −$148.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Revenue: $724.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(1.8%)Operating margin, period not labelled, three months to 2025-07-25. operating income / revenueOperating income: −$13.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $723.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported (Operating income and Revenue not reported)(12.7%)Operating margin, Q3 FY2026, three months to 2026-01-23. operating income / revenueOperating income: −$100.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Revenue: $790.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(11.1%)Operating margin, Q4 FY2026, three months to 2026-04-24. operating income / revenueOperating income: −$93.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Revenue: $837.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure0.6%Operating margin, Q1 FY2027, three months to 2026-07-31. operating income / revenueOperating income: $5.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Net margin%not reported (Revenue not reported)(1.5%)Net margin, period not labelled, three months to 2025-01-24. net income / revenueNet income: −$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Revenue: $687.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(23.8%)Net margin, period not labelled, three months to 2025-04-25. net income / revenueNet income: −$172.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Revenue: $724.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(2.6%)Net margin, period not labelled, three months to 2025-07-25. net income / revenueNet income: −$19.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $723.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported (Revenue not reported)(15.1%)Net margin, Q3 FY2026, three months to 2026-01-23. net income / revenueNet income: −$119.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Revenue: $790.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figure(22.1%)Net margin, Q4 FY2026, three months to 2026-04-24. net income / revenueNet income: −$185.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Revenue: $837.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure0.0%Net margin, Q1 FY2027, three months to 2026-07-31. net income / revenueNet income: $0. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Revenue: $843.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Diluted EPS$ per sharenot reported (Diluted EPS not reported)(0.04)Diluted EPS, period not labelled, three months to 2025-01-24−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figurenot reported (Diluted EPS not reported)(0.08)Diluted EPS, period not labelled, three months to 2025-07-25−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported (Diluted EPS not reported)(0.47)Diluted EPS, Q3 FY2026, three months to 2026-01-23−$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-04-17, accession 0001628280-26-025777.Report this figurenot reported (Diluted EPS not reported)0.00Diluted EPS, Q1 FY2027, three months to 2026-07-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure
Free cash flow$mnot reported (Operating cash flow and Capital expenditure not reported)not reported (Operating cash flow and Capital expenditure not reported)26.0Free cash flow, period not labelled, three months to 2025-04-25. operating cash flow − capital expenditureOperating cash flow: $83.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Capital expenditure: $57.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(194)Free cash flow, period not labelled, three months to 2025-07-25. operating cash flow − capital expenditureOperating cash flow: −$141.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Capital expenditure: $53.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figurenot reported (Operating cash flow and Capital expenditure not reported)not reported (Operating cash flow and Capital expenditure not reported)(226)Free cash flow, Q4 FY2026, three months to 2026-04-24. operating cash flow − capital expenditureOperating cash flow: −$170.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Capital expenditure: $56.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001628280-26-045915. Derived: 12-month figure less the 9-month figure.Report this figure(90.0)Free cash flow, Q1 FY2027, three months to 2026-07-31. operating cash flow − capital expenditureOperating cash flow: −$49.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Capital expenditure: $41.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-09-08, accession 0001628280-26-060926.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$3.10bnGross margin 54.2%
Diluted EPS−$1.30, FY2026
Free cash flow−$420.0m, FY2026
MiniMed Group, Inc., key figures for the last five fiscal years
Line itemUnitFY2024-04-26FY2025-04-25FY20262026-04-24Shape over the periods
Revenue$m2,469Revenue, period not labelled, twelve months to 2024-04-26$2.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure2,715Revenue, period not labelled, twelve months to 2025-04-25$2.71bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure3,102Revenue, FY2026, twelve months to 2026-04-24$3.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure
Gross margin%58.2%Gross margin, period not labelled, twelve months to 2024-04-26. gross profit / revenueGross profit: $1.44bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $2.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure56.3%Gross margin, period not labelled, twelve months to 2025-04-25. gross profit / revenueGross profit: $1.53bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $2.71bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure54.2%Gross margin, FY2026, twelve months to 2026-04-24. gross profit / revenueGross profit: $1.68bn. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $3.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure
Operating margin%(2.8%)Operating margin, period not labelled, twelve months to 2024-04-26. operating income / revenueOperating income: −$69.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $2.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(5.4%)Operating margin, period not labelled, twelve months to 2025-04-25. operating income / revenueOperating income: −$146.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $2.71bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(6.1%)Operating margin, FY2026, twelve months to 2026-04-24. operating income / revenueOperating income: −$190.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $3.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure
Net margin%(4.5%)Net margin, period not labelled, twelve months to 2024-04-26. net income / revenueNet income: −$112.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $2.47bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(7.8%)Net margin, period not labelled, twelve months to 2025-04-25. net income / revenueNet income: −$213.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $2.71bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(10.7%)Net margin, FY2026, twelve months to 2026-04-24. net income / revenueNet income: −$333.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-06-29, accession 0001628280-26-045915.Revenue: $3.10bn. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure
Diluted EPS$ per share(0.44)Diluted EPS, period not labelled, twelve months to 2024-04-26−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(0.84)Diluted EPS, period not labelled, twelve months to 2025-04-25−$0.84 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(1.30)Diluted EPS, FY2026, twelve months to 2026-04-24−$1.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure
Free cash flow$m(107)Free cash flow, period not labelled, twelve months to 2024-04-26. operating cash flow − capital expenditureOperating cash flow: $41.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001628280-26-045915.Capital expenditure: $148.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(53.0)Free cash flow, period not labelled, twelve months to 2025-04-25. operating cash flow − capital expenditureOperating cash flow: $140.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001628280-26-045915.Capital expenditure: $193.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure(420)Free cash flow, FY2026, twelve months to 2026-04-24. operating cash flow − capital expenditureOperating cash flow: −$197.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-06-29, accession 0001628280-26-045915.Capital expenditure: $223.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-06-29, accession 0001628280-26-045915.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Dec 2024 to Nov 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding MiniMed Group, Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
MASSACHUSETTS FINANCIAL SERVICES CO /MA/2026-06-30$124.6m8,334,738Added+1,456,278
MILLENNIUM MANAGEMENT LLC2026-06-30$45.8m3,060,615Added+467,181
CITADEL ADVISORS LLC2026-06-30$42.8m2,865,703Added+14,164
Longaeva Partners L.P.2026-06-30$42.1m2,812,970Reduced−365,684
Sessa Capital IM, L.P.2026-06-30$29.9m2,000,000Unchanged
BlackRock, Inc.2026-06-30$29.8m1,996,489Added+1,970,314
NORGES BANK2026-06-30$29.3m1,961,002New+1,961,002
Rock Springs Capital Management LP2026-06-30$22.7m1,520,000Added+465,000
ExodusPoint Capital Management, LP2026-06-30$21.5m1,437,067Added+1,027,819
FMR LLC2026-06-30$16.2m1,080,689Reduced−284,311

Recent filings

All 108 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

MiniMed Group, Inc., recent filings
FiledFormWhat it isAccession number
2026-10-1608:30 ET8-K5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001104659-26-116441
2026-10-1306:00 ET8-K5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001104659-26-115141
2026-09-0816:28 ET10-QQuarterly reportPeriod 2026-07-310001628280-26-060926
2026-09-0106:50 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-059699
2026-08-2116:15 ETDEF 14AProxy statementPeriod 2026-10-090001140361-26-034021
2026-08-0516:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-26-091115
2026-06-2912:09 ET10-KAnnual reportPeriod 2026-04-240001628280-26-045915
2026-06-2909:22 ET8-K5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-26-078588
2026-06-0306:50 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001628280-26-040036
2026-05-1817:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001104659-26-063267

Latest annual report

Form 10-K for the fiscal year ended Apr 24, 2026Filed Jun 29, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Not in this season’s league. The league lists companies whose quarter has ended and whose results are not yet filed.This season’s league

About the filer

CIK
2062583
Tickers
MMED, MMEDV
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Non-accelerated filer
Former names
MDT Sub Holdings, Inc. (to 2025-05-30)

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 17:19 ET. Listed shows no prices and gives no investment advice.